+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Brachytherapy Devices Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011098
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Brachytherapy Devices Market demonstrates accelerating innovation, growing clinical value, and evolving delivery models. Stakeholders are adapting device portfolios and operational strategies to meet contemporary oncology demands while managing regulatory and supply chain complexities.

Market Snapshot: Brachytherapy Devices Market

The Brachytherapy Devices Market grew from USD 1.60 billion in 2025 to USD 1.83 billion in 2026. It is expected to continue growing at a CAGR of 14.03%, reaching USD 4.03 billion by 2032. Market expansion is driven by advances in precision radiotherapy, increased adoption of outpatient care solutions, and ongoing development of supportive technologies for targeting tumors and safeguarding healthy tissue.

Scope & Segmentation of the Brachytherapy Devices Market

  • Product Types: Encompasses High Dose Rate (HDR), Low Dose Rate (LDR), and Pulsed Dose Rate (PDR) platforms, with delivery systems ranging from remote afterloaders to seed implantation solutions.
  • Clinical Applications: Addresses diverse indications including breast, cervical, ocular, and prostate cancers, each with unique workflow, localization, and verification demands.
  • Source Categories: Covers sealed isotopes such as Cs-137, I-125, Ir-192, and Pd-103, necessitating specific handling, safety, and inventory protocols.
  • End-User Settings: Includes Ambulatory Surgical Centres seeking compact, rapid-turnover platforms; Cancer Research Centers valuing modularity and protocol flexibility; Hospitals prioritizing enterprise integration and multidisciplinary compliance.
  • Technologies: Integrates image-guided brachytherapy, advanced treatment planning software, novel applicator designs, additive manufacturing for patient-specific components, and machine learning-driven planning optimization.
  • Regions: Analysis spans the Americas, Europe, Middle East & Africa, and Asia-Pacific, reflecting regulatory variation, deployment trends, and supply chain approaches.

Key Takeaways for Senior Decision-Makers

  • Localized radiotherapy delivered through brachytherapy is a pillar of modern oncologic care, enabling targeted treatment and reducing impact on healthy tissue.
  • Device selection is increasingly influenced by the need for operational resilience, technological interoperability, and compatibility with outpatient and low-footprint settings.
  • Innovations in digital tools, imaging integration, and customizable applicators are shifting workflows, improving dose precision, and expanding eligibility across patient populations.
  • Procurement and capital planning must address evolving regulatory frameworks, procedural complexity, and continuity of supply—particularly under changing geopolitical influences and tariff policies.
  • Segmentation by product type, clinical use case, and end-user reveals that technology adoption varies markedly across clinical environments, suggesting the need for tailored support and post-market services.

Tariff Impact: Addressing Supply Chain and Regulatory Dynamics

United States tariff actions in 2025 have increased costs for key components, including precision-machined parts and critical electronics, impacting manufacturers reliant on global supply chains. Device makers and healthcare providers are adjusting procurement strategies, enhancing inventory buffers, and considering alternative sourcing—including onshoring—to maintain continuity and manage capital risk. Tariffs affecting cross-border movement of isotopes or sealed sources have added complexity, requiring strengthened customs compliance, greater collaboration among stakeholders, and more resilient supply continuity plans.

Methodology & Data Sources

This report draws on systematic literature review, clinician and supply chain expert interviews, regulatory document analysis, and triangulation against peer-reviewed evidence. Qualitative and quantitative findings were validated through cross-referencing protocols, ensuring accuracy and relevance for strategic planning and operational execution.

Why This Report Matters for B2B Stakeholders

  • Provides actionable insight into evolving device technologies, clinical integration requirements, and procurement strategies.
  • Equips leaders to plan for regulatory shifts, supply chain vulnerabilities, and real-world clinical adoption pressures across global markets.
  • Supports the alignment of product development and commercialization strategies with contemporary care delivery models and operational priorities.

Conclusion

Brachytherapy devices are central to precision oncology, with technology, operations, and regulatory forces shaping market direction. Organizations positioned for success are those investing in integration, supply resilience, and patient-centered design while advancing clinical evidence and collaborative partnerships.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Brachytherapy Devices Market, by Product Type
8.1. High Dose Rate
8.2. Low Dose Rate
8.3. Pulsed Dose Rate
9. Brachytherapy Devices Market, by Source Type
9.1. Cs-137
9.2. I-125
9.3. Ir-192
9.4. Pd-103
10. Brachytherapy Devices Market, by Application
10.1. Breast Cancer
10.2. Cervical Cancer
10.3. Ocular Tumors
10.4. Prostate Cancer
11. Brachytherapy Devices Market, by End User
11.1. Ambulatory Surgical Centres
11.2. Cancer Research Centers
11.3. Hospitals
12. Brachytherapy Devices Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Brachytherapy Devices Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Brachytherapy Devices Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Brachytherapy Devices Market
16. China Brachytherapy Devices Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Becton, Dickinson and Company
17.6. Biobot Surgical Pte Ltd.
17.7. Boston Scientific Corporation
17.8. C4 Imaging LLC
17.9. Carl Zeiss AG
17.10. CivaTech Oncology
17.11. Dexur Inc.
17.12. Eckert & Ziegler BEBIG S.A.
17.13. Elekta AB
17.14. General Electric Company
17.15. Guangzhou Perception Vision Medical Technologies Co.,Ltd.
17.16. Hologic Inc.
17.17. iCAD, Inc.
17.18. IsoAid, LLC
17.19. Merit Medical Systems, Inc.
17.20. Mick Radio-Nuclear Instruments Inc.
17.21. Panacea Medical Technologies Pvt. Ltd.
17.22. Perspective Therapeutics
17.23. Qfix
17.24. SeeDOS Ltd.
17.25. Siemens Healthineers AG
17.26. Sun Nuclear Corporation
17.27. Theragenics Corporation
17.28. Valco Instruments Company Incorporated
17.29. Varian Medical Systems Inc.
List of Figures
FIGURE 1. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BRACHYTHERAPY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BRACHYTHERAPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH DOSE RATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH DOSE RATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HIGH DOSE RATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW DOSE RATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW DOSE RATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY LOW DOSE RATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PULSED DOSE RATE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PULSED DOSE RATE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PULSED DOSE RATE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CS-137, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CS-137, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CS-137, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY I-125, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY I-125, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY I-125, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY IR-192, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY IR-192, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY IR-192, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PD-103, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PD-103, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PD-103, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CERVICAL CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CERVICAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CERVICAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY OCULAR TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY OCULAR TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY OCULAR TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTRES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CANCER RESEARCH CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CANCER RESEARCH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY CANCER RESEARCH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 50. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 51. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 52. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 53. AMERICAS BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 54. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 56. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 57. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 58. NORTH AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 59. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 61. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 62. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 63. LATIN AMERICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 69. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 71. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 72. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 73. EUROPE BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 74. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 76. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 77. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 78. MIDDLE EAST BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 79. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 81. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 82. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 83. AFRICA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 92. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 93. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. ASEAN BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 95. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 96. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 97. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 98. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 99. GCC BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 100. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 102. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 103. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 104. EUROPEAN UNION BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 107. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 108. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 109. BRICS BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 112. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 113. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 114. G7 BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 115. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 117. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 118. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 119. NATO BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL BRACHYTHERAPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 122. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 123. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 124. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 125. UNITED STATES BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 126. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 127. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 128. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY SOURCE TYPE, 2018-2032 (USD MILLION)
TABLE 129. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. CHINA BRACHYTHERAPY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Brachytherapy Devices market report include:
  • Becton, Dickinson and Company
  • Biobot Surgical Pte Ltd.
  • Boston Scientific Corporation
  • C4 Imaging LLC
  • Carl Zeiss AG
  • CivaTech Oncology
  • Dexur Inc.
  • Eckert & Ziegler BEBIG S.A.
  • Elekta AB
  • General Electric Company
  • Guangzhou Perception Vision Medical Technologies Co.,Ltd.
  • Hologic Inc.
  • iCAD, Inc.
  • IsoAid, LLC
  • Merit Medical Systems, Inc.
  • Mick Radio-Nuclear Instruments Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • Perspective Therapeutics
  • Qfix
  • SeeDOS Ltd.
  • Siemens Healthineers AG
  • Sun Nuclear Corporation
  • Theragenics Corporation
  • Valco Instruments Company Incorporated
  • Varian Medical Systems Inc.

Table Information